AB
VYGR icon

Amalgamated Bank’s Voyager Therapeutics VYGR Stock Holding History

Amalgamated Bank’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,463
Closed -$6K – 2793
2025
Q4 		$6K Buy
1,463
+81
+6% +$358 ﹤0.01% 2682
2025
Q3 		$6K Hold
1,382
– – ﹤0.01% 2718
2025
Q2 		$4K Hold
1,382
– – ﹤0.01% 2889
2025
Q1 		$5K Hold
1,382
– – ﹤0.01% 2697
2024
Q4 		$8K Hold
1,382
– – ﹤0.01% 2572
2024
Q3 		$8K Hold
1,382
– – ﹤0.01% 2587
2024
Q2 		$11K Buy
1,382
+311
+29% +$2.61K ﹤0.01% 2411
2024
Q1 		$10K Sell
1,071
-3,426
-76% -$28.9K ﹤0.01% 2464
2023
Q4 		$38K Sell
4,497
-319
-7% -$2.31K ﹤0.01% 2368
2023
Q3 		$37K Hold
4,816
– – ﹤0.01% 2380
2023
Q2 		$55K Buy
+4,816
New +$49.8K ﹤0.01% 2282

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Amalgamated Bank's VYGR Position: Q1 2026 in Review

Amalgamated Bank sold out of Voyager Therapeutics (VYGR) in Q1 2026, closing a stake of 1,463 shares — an estimated $6K sold.

Amalgamated Bank first reported a position in VYGR in Q2 2023 and held it in 11 quarters. The position peaked at $55K in Q2 2023. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Amalgamated Bank reported no remaining Voyager Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,463 Voyager Therapeutics shares in Q1 2026, an estimated $6K.
  • Amalgamated Bank first reported a position in Voyager Therapeutics in Q2 2023 and held it in 11 quarters.
  • Amalgamated Bank's Voyager Therapeutics position peaked at $55K in Q2 2023.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.